Search This Blog

Wednesday, June 18, 2025

'Why women are getting Botox in their vaginas after childbirth'

 Last week, “The Valley” star Zack Wickham opened up about his experience with “scrotox” — yes, that’s Botox in the scrotum.

But while that down-below neurotoxin treatment is for cosmetic reasons, a growing number of women are turning to intimate Botox in the name of health, all to ease vaginal pain, spasms and other uncomfortable symptoms that often linger long after childbirth.

The Post spoke with Dr. Sameea Chughtai, a Chicago-based board-certified physician, to learn more about below-the-belt Botox — “boxtox,” if you will — as well as other options for those who don’t want needles near their nether regions.

A significant portion of women continue to have pelvic pain months or even years after childbirth.9nong – stock.adobe.com

“It’s crucial for women to understand that they don’t have to simply endure these discomforts as an unavoidable consequence of childbirth,” she said. 

“Modern medical advancements offer solutions that can significantly alleviate these issues, allowing women to regain their sense of well-being and confidence.”

Why moms are turning to vaginal Botox

“Childbirth can cause muscular damage due to trauma and severe stretching of the pelvic floor muscles,” Chughtai explained. “When these muscles are disrupted, later on women can experience tension, spasms or pain in the pelvic area.”

It’s a widespread issue, with studies suggesting that roughly half of women experience pelvic floor dysfunction within 10 years of giving birth.

While Botox is well-known for its cosmetic benefits, such as reducing wrinkles, it can also be used to relax the pelvic floor muscles, relieving issues like painful intercourse, spasms and overall vaginal discomfort, according to Chughtai.

She noted that childbirth can also trigger or worsen vaginismus, a condition that causes involuntary contractions of vaginal muscles.

“This condition can also be treated by Botox by temporarily relaxing those muscles and allowing other treatment modalities to be more effective,” she said.

The pelvic floor muscles play a crucial role in controlling bladder, bowel and sexual function.VectorMine – stock.adobe.com
The revolution downstairs

The use of Botox in gynecology is still evolving, but Chughtai said a growing body of evidence produced over the last 10 years supports its safety and efficacy in certain patients.

“As research continues, Botox is likely to become an even more integral part of the therapeutic arsenal for physicians addressing challenging cases of pelvic pain and chronic vaginal discomfort,” she said.

While so-called female rejuvenation treatments are gaining traction, Chughtai said they are still largely unknown to many women who could benefit from them.

Those benefits, she said, extend far beyond physical relief.

Botox is used to temporarily paralyze muscles.Andrii Zastrozhnov – stock.adobe.com

“Reclaiming comfort and confidence through treatments like Botox can profoundly improve a woman’s overall quality of life,” Chughtai said.

“When physical discomfort is mitigated, new mothers can better focus on bonding with their baby, engaging in daily activities with greater ease, and experiencing a more positive and empowered postpartum journey.”


What happens during a vaginal Botox session?

First, patients undergo an evaluation so doctors can tailor the treatment to their needs.

Then, a numbing cream or mild anesthetic is applied before Botox is injected into the pelvic floor muscles — usually two to four shots depending on the case.

“During the procedure, most patients report experiencing only minimal discomfort, often describing the sensation as a fleeting pinch or a mild, transient pressure,” Chughtai said. 

For vaginismus, Botox can be used with vaginal wands. A thin tube with a camera and light is inserted into the bladder so doctors can inject Botox directly into the bladder wall to stop spasms.

Pelvic pain can impact day-to-day activities and quality of life.Getty Images
Bouncing back fast

Most patients get back to their regular routine soon after the injections.

“We advise refraining from sexual activity, strenuous exercise, and heavy lifting for approximately 48 hours,” Chughtai said.

“Any mild soreness or spotting you might experience should resolve rapidly,” she added.

The effects usually last four to six months. How long the relief sticks around depends on several factors, including the dose administered, metabolism, muscle activity and how bad the problem is.

“Many women opt for periodic follow-up treatments to ensure ongoing comfort and sustained relief,” Chughtai said. “Repeated injections over time can help prolong the treatment’s effect by retraining specific muscles.”

The pelvic floor muscles can be stretched, torn or otherwise injured during delivery.New Africa – stock.adobe.com

Needle-phobic? Try these options

If you aren’t into needles, Botox isn’t your only option.

Pelvic floor physical therapy is a often go-to for new moms dealing with muscle tightness, weakness or pain after childbirth.

“This therapy typically involves manual therapy, biofeedback, relaxation training and personalized exercise plans,” Chughtai explained.

“Improvements can often be seen within weeks to months, making it a valuable alternative to consider before injections,” she added.

Vaginal dilators are another tool to ease muscle tightness and pain.

Pelvic floor physical therapy aims to improve the strength, coordination and flexibility of the muscle group.Maridav – stock.adobe.com

“Consistent use, several times per week, is crucial for effectively retraining the muscles over time,” Chughtai noted.

Other gadgets like electrical stimulation can strengthen muscles, while biofeedback sensors and perineal massage tools help soften scar tissue.

Meanwhile, radiofrequency and laser treatments tackle issues like vaginal atrophy, tightening, and urinary problems linked to childbirth.

Muscle relaxants, topical estrogen, and nerve pain meds are also used short-term alongside physical therapy.

“Nerve blocks specifically for the pudendal nerve and non-botox trigger point injections have been used for the more severe cases,” Chughtai said.

“Surgery is another option reserved for patients who have more structural problems like prolapse, incontinence and muscles that have torn and not responded to other therapies,” she added.

https://nypost.com/2025/06/18/health/why-women-are-getting-botox-in-their-vaginas-after-childbirth/

Supreme Court upholds Tennessee ban on transgender treatment for minors

 The Supreme Court on Wednesday upheld Tennessee’s ban on transgender puberty blockers and hormone therapy treatments for minors in a 6-3 decision in a major win for half of US states that have similar laws on the books.

Chief Justice John Roberts authored the majority opinion backed by his five fellow conservative justices, which held that Tennessee’s law doesn’t violate the 14th Amendment’s Equal Protection Clause. The three liberal justices dissented.

“This case carries with it the weight of fierce scientific and policy debates about the safety, efficacy, and propriety of medical treatments in an evolving field,” Roberts acknowledged in the majority opinion.

“Our role … is only to ensure that it does not violate the equal protection guarantee of the Fourteenth Amendment,” he went on. “Having concluded it does not, we leave questions regarding its policy to the people, their elected representatives, and the democratic process.”

In 2023, Tennessee passed Senate Bill 1, to prohibit health care providers from administering procedures on minors “the purpose of enabling a minor to identify with, or live as, a purported identity inconsistent with the minor’s sex.” The law includes exemptions for children with congenital defects or chromosomal anomalies.

The Biden administration, three transgender minors, their parents, and a doctor promptly challenged the law, drawing mixed decisions in the lower courts, the most recent of which — the US Court of Appeals for the Sixth Circuit — backed Tennessee.

Protesters at the Supreme Court rally for transgender rights on Dec. 4, 2024.The Washington Post via Getty Images

More than 1.6 million Americans ages 13 and older identify as transgender, according to data cited by the Supreme Court.

A district court had found that the plaintiffs lacked standing to challenge the ban on transgender surgeries for minors, which is why the Supreme Court focused on its implications for puberty blockers and hormone therapy treatments specifically. The law’s ban on surgeries for transgender minors was not before the high court. 

Plaintiffs argued that the law is based on sex-based classifications and should therefore face heightened scrutiny — a rigorious standard — over whether it violates the Equal Protection Clause’s protections against sex discrimination. 

Whether or not SB1 is subject to heightened scrutiny was the central question before the Supreme Court. The majority opinion found it does not because it is essentially relying on sex neutral classifications and therefore upheld the law. 

“SB1 incorporates two classifications. First, SB1 classifies on the basis of age…Second, SB1 classifies on the basis of medical use,” Roberts noted in his opinion. “Neither of the above classifications turns on sex.”

“Rather, SB1 prohibits healthcare providers from administering puberty blockers and hormones to minors for certain medical uses, regardless of a minor’s sex,” he added. “This Court has never suggested that mere reference to sex is sufficient to trigger heightened scrutiny.”

Roberts also rejected concerns that the Tennessee law discriminated against individuals on the basis of their transgender status, concluding that the state merely removed one option from the “range of treatable conditions” for minors and that individuals over the age of 18 could still receive them.

Liberal Justice Sonia Sotomayor penned a scathing dissent and read it aloud from the bench on Wednesday to underscore her fierce objections. 

“The majority subjects a law that plainly discriminates on the basis of sex to mere rational-basis review. By retreating from meaningful judicial review exactly where it matters most, the Court abandons transgender children and their families to political whims. In sadness, I dissent,” she wrote. 

“When provided in appropriate cases, gender-affirming medical care can meaningfully improve the health and well-being of transgender adolescents, reducing anxiety, depression, suicidal ideation, and (for some patients) the need for more invasive surgical treatments later in life,” she added.

“Tennessee’s ban applies no matter what the minor’s parents and doctors think, with no regard for the severity of the minor’s mental health conditions or the extent to which treatment is medically necessary for an individual child.”

Her dissent was backed by fellow liberal Justices Ketanji Brown Jackson in whole and Elena Kagan in part. It took direct aim at Robert’s premise that SB1 targeted “medical purpose” and “age,” arguing that the flaw in his logic is that “SB1 prohibits is defined by reference to the patient’s sex.”

“SB1 does not just mention sex. It defines an entire category of prohibited conduct based on inconsistency with sex,” she continued. “And it is hard to imagine a law that prohibits conduct ‘inconsistent with’ sex that could avoid intermediate scrutiny.”

Kagan issued a separate dissent, noting that she agreed with Sotomayor that SB1 qualifies for heightened scrutiny but that she takes “no view on how SB1 would fare under heightened scrutiny.”

Liberal Justice Sonia Sotomayor penned a scathing dissent and read it aloud from the bench on Wednesday to underscore her fierce objections. The Washington Post via Getty Images

One key area that Robert’s majority opinion did not address is whether laws that make classifications on the basis of one’s status as transgender should face heightened scrutiny, the way that sex discrimination would.

Conservative Justice Amy Coney Barrett filed a concurring opinion joined by fellow conservative Justice Clarence Thomas, concluding that classifications in law on transgender status should not be subject to heightened scrutiny.

“Indeed, this Court ‘has not recognized any new constitutionally protected classes in over four decades, and instead has repeatedly declined to do so,'” she wrote. “For purposes of the Fourteenth Amendment, the relevant question is whether the group has been subject to a longstanding pattern of discrimination in the law. In other words, we ask whether the group has suffered a history of de jure discrimination. Existing suspect classes had such a history.”

“Beyond the treatment of gender dysphoria, transgender status implicates several other areas of legitimate regulatory policy—ranging from access to restrooms to eligibility for boys’ and girls’ sports teams,” she added. “If laws that classify based on transgender status necessarily trigger heightened scrutiny, then the courts will inevitably be in the business of ‘closely scrutiniz[ing] legislative choices’ in all these domains.”

Thomas and conservative Justice Samuel Alito also filed additional concurring opinions addressing other technical aspects of the case. 

The case, United States v. Skrmetti, was one of the most high-profile issues on the Supreme Court’s docket this term, alongside President Trump’s challenge against birthright citizenship, a case that is really more about the extent of lower court powers to block presidential actions.

https://nypost.com/2025/06/18/us-news/supreme-court-upholds-tennessee-ban-on-transgender-surgeries-for-minors/

2 including bystander stabbed in rush-hour clash at Grand Central subway, suspect on run

 Two men were stabbed – including an innocent bystander – when an argument between strangers turned bloody on board a train passing through Grand Central during the Wednesday morning rush.

A 32-year-old straphanger was stabbed in the stomach and buttocks when a clash between him and another rider became violent on board a southbound No. 5 train at the 42nd Street-Grand Central station at 7:20 a.m., according to authorities.

Two people were stabbed on Wednesday morning on the Grand Central Terminal subway mezzanine.Fox 5 New York
MTA police on the subway platform at Grand Central.James Messerschmidt

A 28-year-old man, who was not involved in the dispute, somehow got caught in the middle of the skirmish and was knifed in the stomach, police said. 

It wasn’t immediately clear what started the argument.

Two people were stabbed during the morning rush at Grand Central.Fox 5 New York

Both victims were taken to Bellevue Hospital, where they were listed in stable condition.

The suspect, meanwhile, bolted after the attack. No arrests had been made by Wednesday afternoon.

The subway menace is described as a man with a dark complexion, believed to be about 30 years old and 150 pounds with a slim build, last seen wearing a black jacket and black hat, police said. 

https://nypost.com/2025/06/18/us-news/two-men-stabbed-during-morning-rush-at-grand-central-subway-station-suspect-on-the-run/

Hormuz Disruption Fears Surge After Former Iranian Minister Threatens Transit Restrictions

JPMorgan's forecast of triple-digit Brent crude prices could soon be a reality as conflict risk in and around the Strait of Hormuz intensifies. The waterway, which handles roughly 20% of global oil trade, remains one of the world's most critical maritime chokepoints. Any disruption, particularly amid growing military escalation between Iran and Israel, could impact energy flows worldwide and send prices soaring. 

The most concerning sign of potential maritime disruption in the Strait of Hormuz emerged in the overnight hours via a statement on X by former Iranian Economy Minister Ehsan Khandouzi. While unofficial, the timing and seniority of the comment may reflect broader regime sentiment—or serve as a warning of what's to come.

"Starting tomorrow, for 100 days, no oil tankers or LNG cargoes will be able to pass through the strait without Iran's approval," Khandouzi said. 

He stated, "This policy is decisive if it is implemented "in a timely manner." Any delay in its implementation means enduring more war inside the country. Trump's battle must be ended with a combination of economy and security." 

Such messaging, especially when paired with the Islamic Revolutionary Guard Corps (IRGC) naval activity in the region, raises the increasing probability of IRGC actions targeting commercial shipping lanes in the strait. This escalation could serve as the catalyst that turns JPMorgan's $120–$130 per barrel Brent crude forecast from a scenario into a market reality.

Some more excerpts from the full JPM note

A blockade of the Strait of Hormuz—the world's busiest oil-shipping channel—would shut down the region's oil trade, supercharging oil prices.

The skinny waterway—at its narrowest point it is only 21 miles (33 km) wide— separating the UAE, Oman and Iran, connects the Persian Gulf with the Indian Ocean, and facilitates the movement of some 30% of the world's seaborne oil trade and 20% of the world's LNG supply (Table 1).

Widespread GPS jamming has been reported across the strait for the last several days:

Which unfolded into a maritime disaster early Tuesday when crude oil tanker Front Eagle slammed into the port quarter of the tanker Adalynn, sparking a massive fire on Adalynn, and concerns about a potential ecological disaster have surged. 

All in all, the world's most critical maritime chokepoint appears to be in the crosshairs of the Iranian regime. On Tuesday, President Trump met with his national security team for over an hour to discuss the Middle East and later held a call with Israeli Prime Minister Netanyahu.

The key question now is whether the U.S. will enter the conflict. If it does, a shipping disruption in the Strait of Hormuz is almost guaranteed—setting the stage for global energy markets to be thrown into turmoil.

https://www.zerohedge.com/geopolitical/strait-hormuz-disruption-fears-surge-after-former-iranian-minister-threatens-transit

Amgen Monthly Obesity Treatment MariTide Achieves Continuous Weight Loss at 52 Weeks

Amgen will present key data for MariTide, its investigational monthly obesity and Type 2 diabetes treatment, at the American Diabetes Association's 85th Scientific Sessions. The presentation will showcase 52-week efficacy and safety data from Phase 2 studies, showing significant weight loss without plateauing in patients with and without Type 2 diabetes. MariTide represents a breakthrough as the first monthly or less frequently dosed peptide-antibody conjugate for obesity treatment. The company will also present new Repatha data regarding lipid-lowering therapy benefits in Type 1 diabetes patients. Amgen will host an investor webcast on June 23, 2025, at 4:30 p.m. CDT to discuss the MariTide program. The scientific sessions will feature additional presentations on cardiovascular efficacy and lipid-lowering therapy patterns from the FOURIER and VESALIUS-REAL studies.